肺腺癌中的ARID1A基因驱动突变 - Suppr | 超能文献

ARID1A Gene Driver Mutations in Lung Adenocarcinomas.

作者信息

Karachaliou Niki, Paulina Bracht Jillian Wilhelmina, Rosell Rafael

机构信息

Institute of Oncology Rosell, University Hospital Sagrat Cor, QuironSalud Group and Pangaea Oncology, Laboratory of Molecular Oncology, Quiron-Dexeus University Institute, Barcelona, Spain.

Catalan Institute of Oncolgy, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol, Badalona, Spain; Institute of Oncology Rosell, Quiron-Dexeus University Institute; Pangaea Oncology, Laboratory of Molecular Oncology, Quiron-Dexeus University Institute, Barcelona, Spain.

出版信息

J Thorac Oncol. 2018 Dec;13(12):e255-e257. doi: 10.1016/j.jtho.2018.07.099.

DOI:10.1016/j.jtho.2018.07.099

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

ARID1A Gene Driver Mutations in Lung Adenocarcinomas.

J Thorac Oncol. 2018 Dec;13(12):e255-e257. doi: 10.1016/j.jtho.2018.07.099.

2

Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.

Cancer Biomark. 2020;27(4):525-532. doi: 10.3233/CBM-191204.

3

High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant.

Clin Lung Cancer. 2020 Mar;21(2):e37-e44. doi: 10.1016/j.cllc.2019.11.012. Epub 2019 Nov 28.

4

Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.

Int J Med Sci. 2018 Nov 5;15(14):1676-1685. doi: 10.7150/ijms.28728. eCollection 2018.

5

LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.

BMC Cancer. 2019 Mar 22;19(1):263. doi: 10.1186/s12885-019-5433-7.

6

Primary Lung Cribriform Adenocarcinoma With Squamoid Morules Harboring Somatic Mutation in a Never-Smoked Healthy Adolescent.

Pediatr Dev Pathol. 2020 Nov-Dec;23(6):472-475. doi: 10.1177/1093526620957219. Epub 2020 Sep 13.

7

CDK1 serves as a potential prognostic biomarker and target for lung cancer.

J Int Med Res. 2020 Feb;48(2):300060519897508. doi: 10.1177/0300060519897508.

8

Genomic alterations of ground-glass nodular lung adenocarcinoma.

Sci Rep. 2018 May 16;8(1):7691. doi: 10.1038/s41598-018-25800-2.

9

KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.

J Thorac Oncol. 2016 Apr;11(4):496-503. doi: 10.1016/j.jtho.2016.01.010. Epub 2016 Jan 30.

10

Concomitant Epidermal Growth Factor Receptor Mutation and EML4-ALK Fusion in a Patient with Multifocal Lung Adenocarcinomas.

J Thorac Oncol. 2018 Mar;13(3):e45-e48. doi: 10.1016/j.jtho.2017.11.130.

引用本文的文献

1

Small bowel metastatic SWI/SNF-deficient undifferentiated carcinoma may be predictive of lung primary-a rare presentation with novel SMARCA2 mutation findings in a study of three cases.

Virchows Arch. 2025 Aug 7. doi: 10.1007/s00428-025-04208-0.

2

Modeling lung adenocarcinoma metastases using patient-derived organoids.

Cell Rep Med. 2024 Oct 15;5(10):101777. doi: 10.1016/j.xcrm.2024.101777.

3

The Role of the AT-Rich Interaction Domain 1A Gene () in Human Carcinogenesis.

Genes (Basel). 2023 Dec 19;15(1):5. doi: 10.3390/genes15010005.

4

The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma.

Heliyon. 2023 Mar 8;9(3):e14307. doi: 10.1016/j.heliyon.2023.e14307. eCollection 2023 Mar.

5

Status Assessment for Better Care of Early Stage Non-Small Cell Lung Carcinoma: What Is Changing in the Daily Practice of Pathologists?

Cells. 2021 Aug 21;10(8):2157. doi: 10.3390/cells10082157.

6

ARID1A genomic alterations driving microsatellite instability through somatic MLH1 methylation with response to immunotherapy in metastatic lung adenocarcinoma: a case report.

J Med Case Rep. 2021 Feb 19;15(1):89. doi: 10.1186/s13256-020-02589-1.

7

A case report on concurrent occurrence of systemic mastocytosis and myeloid sarcoma presenting with extensive skin involvements and the results of genetic study.

Medicine (Baltimore). 2020 Dec 11;99(50):e21948. doi: 10.1097/MD.0000000000021948.

8

Understanding EGFR heterogeneity in lung cancer.

ESMO Open. 2020 Oct;5(5):e000919. doi: 10.1136/esmoopen-2020-000919.

9

ARID1A mutations and expression loss in non-small cell lung carcinomas: clinicopathologic and molecular analysis.

Mod Pathol. 2020 Nov;33(11):2256-2268. doi: 10.1038/s41379-020-0592-2. Epub 2020 Jun 22.

10

Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.

Biomolecules. 2020 Mar 20;10(3):476. doi: 10.3390/biom10030476.